2oo8: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="2oo8" size="450" color="white" frame="true" align="right" spinBox="true" caption="2oo8, resolution 2.20Å" /> '''Synthesis, Structur...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2oo8.gif|left|200px]]<br />
[[Image:2oo8.gif|left|200px]]<br /><applet load="2oo8" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2oo8" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2oo8, resolution 2.20&Aring;" />
caption="2oo8, resolution 2.20&Aring;" />
'''Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 Inhibitors'''<br />
'''Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 Inhibitors'''<br />
Line 6: Line 5:
==Overview==
==Overview==
A novel class of selective Tie-2 inhibitors was derived from a, multi-kinase inhibitor 1. By reversing the amide connectivity and, incorporating aminotriazine or aminopyridine hinge-binding moieties, excellent Tie-2 potency and KDR selectivity could be achieved with, 3-substituted terminal aryl rings. X-ray co-crystal structure analysis, aided inhibitor design. This series was evaluated on the basis of potency, selectivity, and rat pharmacokinetic parameters.
A novel class of selective Tie-2 inhibitors was derived from a, multi-kinase inhibitor 1. By reversing the amide connectivity and, incorporating aminotriazine or aminopyridine hinge-binding moieties, excellent Tie-2 potency and KDR selectivity could be achieved with, 3-substituted terminal aryl rings. X-ray co-crystal structure analysis, aided inhibitor design. This series was evaluated on the basis of potency, selectivity, and rat pharmacokinetic parameters.
==Disease==
Known diseases associated with this structure: Venous malformations, multiple cutaneous and mucosal OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600221 600221]]


==About this Structure==
==About this Structure==
2OO8 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with RAJ as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2OO8 OCA].  
2OO8 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=RAJ:'>RAJ</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2OO8 OCA].  


==Reference==
==Reference==
Line 23: Line 19:
[[Category: kinase]]
[[Category: kinase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 23:14:01 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 15:04:24 2008''